openPR Logo
Press release

Universal $30.24 Bn HIV Diagnostics Market | Abbott Healthcare, Abbvie, Alere, Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., BD Biosciences, VIIV Healthcare, Partec, Beckman Coulter, bioMerieux, Apogee Flow Systems, Zyomyx , Po

09-14-2018 11:25 AM CET | Health & Medicine

Press release from: Crystal Market Research - Healthcare

HIV Diagnostics Market

HIV Diagnostics Market

The global HIV diagnostics market was evaluated around USD 11.81 billion in the 2012 and is expected to reach approximately USD 30.24 billion by the end of 2022 while registering itself at a compound annual growth rate (CAGR) of 9.86% over the forecast period.

HIV Diagnostics - Competitive Outlook and Trend Analysis

Major market players of the HIV diagnostics market are Abbott Healthcare, Abbvie Inc., Alere Inc., Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co. Inc, BD Biosciences, VIIV Healthcare, Partec, Beckman Coulter, bioMerieux, Apogee Flow Systems, Zyomyx Inc., PointCare Technologies Inc., Mylan Unc., Qiagen, Roche Diagnostics, Siemens Healthcare, and Sysmex. These key players in the global market are involved in the research and development of p24 antigen, CD4, and viral load testing methodologies in order to trim down their implementation complications and enhance portability and accessibility.

Sample copy of this report: .

HIV Diagnostics - Industry Trend Analysis

Owing to the technological advancements of disease diagnostic tests, and the expected commercialization and development of innovative, authorities sanctioned POC and faster p24 antigen, EID, and CD4 tests. There is a rising need to establish easily available, proficient and accurate diagnostics tests. Owing to the financial resource-restricted settings in a major market share of the regions that are impacted by disease; it is still not possible to execute the complex, current screening, monitoring and staging tests. This is either owing to the deficiency of adequate testing labs or a need of skilled technicians competent of executing the tests. These restrictions of lab-based testing are an accelerator to the expansion of easy to implement and portable rapid, point of care tests. At present, a very few number of these tests are accessible in the market worldwide. Though, in the current scenario, a number of rapid or POC tests are under scientific progress and analysis. This anticipated augmenting in a number of product benefits to the global market which is estimated to drive the global HIV diagnostics market growth further during the forecast years.

HIV Diagnostics - The global HIV diagnostics market is segmented as follows –

HIV Diagnostics - By Region:

North America - U.S, Canada, Mexico
Europe - Germany, France, UK, Italy, Spain, Rest of Europe
Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific
Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

HIV Diagnostics - Regional Outlook and Trend Analysis

Global HIV diagnostics market can be classified into Europe, North America, Latin America, Asia-Pacific, and Middle East Asia. In 2014, North American regional HIV diagnostics market reported for the major share of global market revenue due to the existence of a technologically innovative medical framework, encouraging compensation policies and comparatively elevated healthcare spending in research and development. This region is anticipated to experience a rise in market demand further over the projected phase with the technological expansion of portable and rapid diagnostic tests. Though, the Asia-Pacific regional HIV diagnostics market, due to the existence of high unfulfilled demand in China and India, is projected to grow at a comparatively rapid rate during the forecast years.

HIV Diagnostics - By Product: Antibody Tests, HIV-1 Screening Tests, ELISA/EIA, Home Access Dried Blood Spot, Rapid Tests (Dot plot, HIV-1 Antibody Confirmatory Tests, Western Blot Test, Indirect Immunofluorescent Antibody Assay (IFA), Line Immunoassay, RadioImmunoPrecipitation Assay (RIPA), HIV-2 & Group O Diagnostic Tests, Blood Antibody Tests, Dried Blood Spot (DBS) Test, Viral Identification Assays, P24 Antigen Test, Qualitative PCR Tests, Viral Culture, CD4 Testing, Viral Load Testing, Early Infant Diagnostics

HIV Diagnostics - Product Outlook and Trend Analysis

The HIV diagnostics market embraces diagnostic confirmatory and screening tests for HIV-1, 2 and group O occurrence testing. These tests have chief applications to monitor and distinguish between the variety of subtypes and groups of human immunodeficiency virus (HIV). At a wider level, diagnostic products and tests can be segmented into viral identification assays, antibody tests, viral load testing, early infant diagnosis (EID), and CD4 testing. EID is carried out independently than CD4 testing and viral load testing due to the existence of antibodies by maternal blood within infants under the age group of 18 months, outcomes from the abovementioned tests turn out to be incorrect. Hence, DNA PCR molecular test is utilized for infant HIV screening and diagnostics, therefore warranting a different market section reporting for the same. The leading market share for the HIV diagnostics market in 2014 was reported by antibody tests. This major share can be mainly assigned to the existence of a large quantity of antibody tests in this market that can be further again parted into 1 confirmatory, HIV-1 screening, and 2 & Group O tests. These involve modern 4th and 3rd generation POC/NonPOC dried blood spot tests, ELISA tests, western blot, rapid agglutination for HIV-1 screening, radioimmuno-precipitation assay, and indirect immunofluorescent antibody assay, for line immunoassays and disease confirmation for disease. Other test section in the global market involve viral culture and p24 antigen tests for viral identification, CD4 testing, and viral load testing; p24 antigen tests are lesser sensitive as compared to antibody and are utilized in blend with them to render HIV testing functionality and complimentary screening. These tests are necessary for the monitoring and implementation of antiretroviral therapy; once affirmative verification of the contamination is prevailed. In the present market situation, these tests are complicated to use and require laboratories with skilled technicians. The anticipated technological innovations of these testing sections giving augment to the advent of new POC tests is also projected to drive the global HIV diagnostic tests market growth.

Get more information of this report: .

HIV Diagnostics - List of Tables

Table 1.HIV Diagnostics Market, By Product ($Million), 2012-2022
Table 2.Antibody Tests Market, By Type ($Million), 2012-2022
Table 3.Antibody Tests Market, By Region ($Million), 2012-2022
Table 4.HIV-1 Screening Tests Market, By Type ($Million), 2012-2022
Table 5.HIV-1 Screening Tests Market, By Region ($Million), 2012-2022
Table 6.ELISA/EIA Market, By Region ($Million), 2012-2022

HIV Diagnostics - List of Figures

Figure 1.HIV Diagnostics Market, Share, By Product, 2016 & 2025
Figure 2HIV Diagnostics Market, By Region, 2016, ($Million)
Figure 3.Alere Inc.: Net Revenues, 2014-2016 ($Million)
Figure 4.Alere Inc.: Net Revenue Share, By Segment, 2016
Figure 5.Alere Inc.: Net Revenue Share, By Geography, 2016
Figure 6.Beckman Coulter: Net Revenues, 2014-2016 ($Million)
Figure7.Beckman Coulter: Net Revenue Share, By Segment, 2016

What our report offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic recommendations for the new entrants

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends.

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements

Read Premium News from The ABnewswire of Hemodialysis Concentrates Market at: .


About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Universal $30.24 Bn HIV Diagnostics Market | Abbott Healthcare, Abbvie, Alere, Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co., BD Biosciences, VIIV Healthcare, Partec, Beckman Coulter, bioMerieux, Apogee Flow Systems, Zyomyx , Po here

News-ID: 1239300 • Views: 478

More Releases from Crystal Market Research - Healthcare

Viral Vector And Plasmid Dna Manufacturing Market Outlook 2019 | Business Develo …
Crystal Market Research Present Advance research on - Viral Vector And Plasmid Dna Manufacturing Market, approximates that the Viral Vector And Plasmid Dna Manufacturing Industry size is anticipated to flourish at a significant CAGR in the future. The Viral Vector and Plasmid DNA Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Viral vectors and plasmid DNA manufacturing usually incorporates
Medical Digital Imaging Systems Market | Research Report 2019-2025 | Major Compa …
Crystal Market Research Present Advance research on "Medical Digital Imaging Systems Market", approximates that the Medical Digital Imaging Systems Industry size is anticipated to flourish at a significant CAGR in the future. The Medical Imaging is the process and technique of making the visual portrayals of the inside of the body for the purpose of medical intervention and clinical analysis, just as visual portrayal of the functioning of certain tissues (physiology)
Medical Device Complaint Management Market | Research Report 2019-2025 | Major C …
Crystal Market Research Present Advance research on "Medical Device Complaint Management Market", approximates that the Medical Device Complaint Management Industry size is anticipated to flourish at a significant CAGR in the future. The manufacturers of medical gadget must keep record and also track the complaints of customer as per the Quality System Regulation (QSR) characterized in the 21 CFR Part 820. Furthermore, the FDA Part 803 guidelines need the firms
Veterinary Molecular Diagnostics Market | Research Report 2019-2025 | Major Comp …
The Universal Veterinary Molecular Diagnostics Market is anticipated to observe supported development over the foreseen period. The major development factor for the growth of Veterinary Molecular Diagnostics is the positive development in the beverage sector. Moreover, expanding canned food preference and increment in extra cash of the customers is the primary factors which are driving the market. Moreover, high recovery and recycling rate of the metal cans is anticipated to

All 5 Releases

More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral